же существует – это длительность приема. Врач может уделить вам 12 минут, если повезет – 15. Но этого, увы, часто недостаточно. В то время как в частной медицине длительность приема может составлять от 30 минут до l часа. Но как именно распорядится этим временем конкретный специалист, уже другой вопрос.
Заключение
В этой энциклопедии представлена самая важная информация, позволяющая женщине сохранить свое здоровье и принять своевременное и правильное решение при изменении самочувствия.
Сведения и факты, изложенные в книге, призваны помочь почувствовать себя более уверенно на приеме у гинеколога и реже обращаться к недостоверным источникам информации в интернете.
Буду рада, если вы вместе со мной продолжите углублять свои знания в области женской физиологии. Вместе мы продолжим разрушать мифы, изучать факты и основывать свои суждения исключительно на доказанных методах обследования и способах лечения. Давайте идти в ногу со временем!
С заботой о вас,
доктор Суслова
Список источников
4. БОЛЬ
1) Sacco, Simona et al. “Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).” The journal of headache and pain vol. 18,1 108. 30 Oct. 2017, doi:10.1186/s10194-017–0815-1
2) Ornello, R., De Matteis, E., Di Felice, C., Caponnetto, V., Pistoia, F., & Sacco, S. (2021). “Acute and Preventive Management of Migraine during Menstruation and Menopause.” Journal of clinical medicine, 10(11), 2263. https://doi.org/10.3390/jcm10112263
3) Allais, G. et al. “Menstrual migraine: a review of current and developing pharmacotherapies for women.” Expert opinion on pharmacotherapy vol. 19,2 (2018): 123–136. doi:10.1080/14656566.2017.1414182
4) Facchinetti, F. et al. “Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.” Headache vol. 31,5 (1991): 298–301. doi:10.1111/j.1526–4610.1991.hed3105298.x
5) Медицинские критерии приемлемости для использования методов контрацепции ВОЗ. 5-е издание. 2015. URL: https://iris.who.int/bitstream/handle/10665/326788/9789289052689-rus.pdf?sequence=3&isAllowed=y
5. РОСТ ВОЛОС
1) Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789. URL: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/screening-and-management-of-the-hyperandrogenic-adolescent
2) Barrionuevo, Patricia et al. “Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis.” The Journal of clinical endocrinology and metabolism vol. 103,4 (2018): 1258–1264. doi:10.1210/jc.2017–02052
6. МЕНСТРУАЛЬНЫЙ ЦИКЛ
1) Munro, Malcolm G. et al. “The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 143,3 (2018): 393–408. doi:10.1002/ijgo.12666
2) Jones S. L., Campbell B., Hart T. “Laboratory tests commonly used in complementary and alternative medicine: a review of the evidence.” Annals of Clinical Biochemistry. 2019; 56(3):310–325. doi:10.1177/0004563218824622
7. ГОРМОНЫ
1) Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions // The U.S. Preventive Services Task Force. November 01, 2022. URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication#fullrecommendationstart
2) The 2022 hormone therapy position statement of The North American Menopause Society // The Menopouse Society. 2022. URL: https://menopause.org/professional-resources/position-statements
3) Hamoda, Haitham et al. “The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.” Post reproductive health vol. 26,4 (2020): 181–209. doi:10.1177/2053369120957514
4) Hamoda, Haitham et al. “BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.” Post reproductive health vol. 27,1 (2021): 49–55. doi:10.1177/2053369120983154
5) Boardman, Henry M. P. et al. “Hormone therapy for preventing cardiovascular disease in post-menopausal women.” The Cochrane database of systematic reviews vol. 2015,3 CD002229. 10 Mar. 2015, doi:10.1002/14651858.CD002229.pub4
6) Collaborative Group on Hormonal Factors in Breast Cancer. “Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.” Lancet (London, England) vol. 394,10204 (2019): 1159–1168. doi:10.1016/S0140–6736(19)31709-X
7) Chlebowski, Rowan T. et al. “Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials.” JAMA vol. 324,4 (2020): 369–380. doi:10.1001/jama.2020.9482
8) Cordina-Duverger, Emilie et al. “Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.” PloS one vol. 8,11 e78016. 1 Nov. 2013, doi:10.1371/journal.pone.0078016
8. КРОВОТЕЧЕНИЕ
1) Munro, Malcolm G. et al. “FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 113,1 (2011): 3–13. doi:10.1016/j.ijgo.2010.11.011
9. КОНТРАЦЕПЦИЯ
1) Contraception and Birth Control Methods // U. S. Centers for Disease Control and Prevention. August 6, 2024. URL: https://www.cdc.gov/contraception/about/index.html#:~:text=Emergency%2Contraception&text=Emergency%20contraceptive%20pills%E2%80%94Emergency%20contraceptive,the%20better%20they%20will%20work.
2) “Practice Bulletin No. 152: Emergency Contraception.” Obstetrics and gynecology vol. 126,3 (2015): e1-e11. doi:10.1097/AOG.0000000000001047
3) Национальные медицинские критерии приемлемости методов контрацепции 2023: [Электронный ресурс] / Под ред. Г. Т. Сухих, В. Н. Прилепской. М.: ФГБУ НМИЦ акушерства, гинекологии и перинатологии им. академика В. И. Кулакова Министерства Здравоохранения РФ, Российское общество по контрацепции, Российское общество акушеров-гинекологов, 2023. URL: https://roag-portal.ru/news-76
4) Endler, M. et al. “Effect of levonorgestrel emergency contraception on implantation and fertility: A review.” Contraception vol. 109 (2022): 8–18. doi:10.1016/j.contraception.2022.01.006
5) Faculty of Sexual & Reproductive Healthcare. FSRH guideline. Emergency contraception. March 2017 (Amended July 2023). URL: https://www.fsrh.org/Common/Uploaded%20files/documents/fsrh-guideline-emergency-contraception03dec2020-amendedjuly2023–11jul.pdf
6) Mørch, Lina S. et al. “Contemporary Hormonal Contraception and the Risk of Breast Cancer.” The New England journal of medicine vol. 377,23 (2017): 2228–2239. doi:10.1056/NEJMoa1700732
7) Condom Use: An Overview // U. S. Centers for Disease Control and Prevention. January 19, 2024. URL: https://www.cdc.gov/condom-use/index.html#:~:text=Laboratory%20studies%20show%20latex%20condoms,preventing%20the%20spread%20of%20HIV.
10. ЗДОРОВЬЕ И ЗОЖ В ГИНЕКОЛОГИИ
1) USPSTF A&B Recommendations // The U. S. Preventive Services Task Force. Updated 2024. URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
2) Inoue-Choi, Maki et al. “Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States.” JAMA network open vol. 3,6 e206436. 1 Jun. 2020, doi:10.1001/jamanetworkopen.2020.6436
3) Sundermann, Alexandra C. et al. “Alcohol Use in Pregnancy and Miscarriage: A Systematic Review and Meta-Analysis.” Alcoholism, clinical and experimental research vol. 43,8 (2019): 1606–1616. doi:10.1111/acer.14124
4) World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. A summary of the Third Expert Report (2018). URL: https://www.wcrf.org/wp-content/uploads/2021/02/Summary-of-Third-Expert-Report-2018.pdf
5) Freudenheim, Jo. L. “Alcohol’s Effects on Breast Cancer in Women.” Alcohol research: current reviews vol. 40,2 11. 18 Jun. 2020, doi:10.35946/arcr.v40.2.11
6) Allen, Naomi E. et al. “Moderate alcohol intake and cancer incidence in women.” Journal of the National Cancer Institute vol. 101,5 (2009): 296–305. doi:10.1093/jnci/djn514
7) Choi, Yoon-Jung et al. “Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of
